Anti-Mullerian Hormone (AMH) and Antral Follicle Count as Markers of Ovarian Reserve- Prospective Followup of Young Cancer Patients (Ovrescancer)

Hadassah Medical Center

Status: Unknown

Conditions: Infertility

Treatments: Biological: blood tests

Study type: Observational

Funder types: Other

Identifiers

NCT00930501

111222

Details and patient eligibility

About

young female cancer patients have improving chances of survival. the main risk is a chronic damage to their ovarian reserve. This may lead to future infertility.

Full description

our objective is to prospectively follow patients before and after their cancer treatment. this should help us learn of the gonadotoxicity of various treatments as well as be able to better consult these and future patients of the need of fertility preservation techniques.

Enrollment: 100 estimated patients

Sex: Female

Ages: 5 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• all females prior and after chemotherapy

Exclusion criteria

• do not consent

Trial design

100 participants in 1 patient group

Cancer patients

Description:

women 5-45 yr olf pre and post chemotherapy

Treatment:

Biological: blood tests